Search Advanced Search Only of the Type(S) - Any - News Page Press Search results (35) Dr. Sadiq Discusses Phase II at the 2023 AAN Annual Meeting Dr. Sadiq Discusses Phase II at the 2023 AAN Annual Meeting Hear Dr. Sadiq discuss the Phase II trial Outcomes 05/08/2023 - 16:48 Explaining the Phases of Clinical Trial Explaining the Phases of Clinical Trial Learn about the steps we take to conduct and publish research! 01/24/2025 - 16:57 FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients 06/05/2024 - 20:38 Researchers Create Novel Human Brain Model to Understand and Replicate Stem Cell Dysregulation in Multiple Sclerosis Researchers Create Novel Human Brain Model to Understand and Replicate Stem Cell Dysregulation in Multiple Sclerosis 02/08/2023 - 08:00 New Study Reveals New Potential Therapeutic Target for Experimental Multiple Sclerosis Treatment New Study Reveals New Potential Therapeutic Target for Experimental Multiple Sclerosis Treatment 03/07/2023 - 16:31 Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes 02/06/2023 - 16:33 Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace 06/29/2022 - 16:35 New Research Finds MS Patients Had Strong T-Cell Activation In Response to COVID-19 Vaccination New Research Finds MS Patients Had Strong T-Cell Activation In Response to COVID-19 Vaccination 08/09/2022 - 16:37 News - Archive News - Archive Coverage of Tisch MSRCNY news. 02/01/2025 - 15:41 About Us - New About Us - New A stronghold of scientific innovation, redefining what's possible in MS research 02/18/2025 - 12:23 Pagination Page 1 Page 2 Page 3 Page 4
Dr. Sadiq Discusses Phase II at the 2023 AAN Annual Meeting Dr. Sadiq Discusses Phase II at the 2023 AAN Annual Meeting Hear Dr. Sadiq discuss the Phase II trial Outcomes 05/08/2023 - 16:48
Explaining the Phases of Clinical Trial Explaining the Phases of Clinical Trial Learn about the steps we take to conduct and publish research! 01/24/2025 - 16:57
FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients 06/05/2024 - 20:38
Researchers Create Novel Human Brain Model to Understand and Replicate Stem Cell Dysregulation in Multiple Sclerosis Researchers Create Novel Human Brain Model to Understand and Replicate Stem Cell Dysregulation in Multiple Sclerosis 02/08/2023 - 08:00
New Study Reveals New Potential Therapeutic Target for Experimental Multiple Sclerosis Treatment New Study Reveals New Potential Therapeutic Target for Experimental Multiple Sclerosis Treatment 03/07/2023 - 16:31
Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes 02/06/2023 - 16:33
Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace 06/29/2022 - 16:35
New Research Finds MS Patients Had Strong T-Cell Activation In Response to COVID-19 Vaccination New Research Finds MS Patients Had Strong T-Cell Activation In Response to COVID-19 Vaccination 08/09/2022 - 16:37
About Us - New About Us - New A stronghold of scientific innovation, redefining what's possible in MS research 02/18/2025 - 12:23
